Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

482 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
GD2 and GD3 gangliosides as diagnostic biomarkers for all stages and subtypes of epithelial ovarian cancer.
Galan A, Papaluca A, Nejatie A, Matanes E, Brahimi F, Tong W, Hachim IY, Yasmeen A, Carmona E, Klein KO, Billes S, Dawod AE, Gawande P, Jeter AM, Mes-Masson AM, Greenwood CMT, Gotlieb WH, Saragovi HU. Galan A, et al. Front Oncol. 2023 Apr 14;13:1134763. doi: 10.3389/fonc.2023.1134763. eCollection 2023. Front Oncol. 2023. PMID: 37124505 Free PMC article.
Inhibiting the MNK1/2-eIF4E axis impairs melanoma phenotype switching and potentiates antitumor immune responses.
Huang F, Gonçalves C, Bartish M, Rémy-Sarrazin J, Issa ME, Cordeiro B, Guo Q, Emond A, Attias M, Yang W, Plourde D, Su J, Gimeno MG, Zhan Y, Galán A, Rzymski T, Mazan M, Masiejczyk M, Faber J, Khoury E, Benoit A, Gagnon N, Dankort D, Journe F, Ghanem GE, Krawczyk CM, Saragovi HU, Piccirillo CA, Sonenberg N, Topisirovic I, Rudd CE, Miller WH Jr, Del Rincón SV. Huang F, et al. Among authors: galan a. J Clin Invest. 2024 May 1;134(9):e181575. doi: 10.1172/JCI181575. J Clin Invest. 2024. PMID: 38690739 Free PMC article. No abstract available.
Haematopoietic gene therapy of non-conditioned patients with Fanconi anaemia-A: results from open-label phase 1/2 (FANCOLEN-1) and long-term clinical trials.
Río P, Zubicaray J, Navarro S, Gálvez E, Sánchez-Domínguez R, Nicoletti E, Sebastián E, Rothe M, Pujol R, Bogliolo M, John-Neek P, Bastone AL, Schambach A, Wang W, Schmidt M, Larcher L, Segovia JC, Yáñez RM, Alberquilla O, Díez B, Fernández-García M, García-García L, Ramírez M, Galy A, Lefrere F, Cavazzana M, Leblanc T, García de Andoin N, López-Almaraz R, Catalá A, Barquinero J, Rodríguez-Perales S, Rao G, Surrallés J, Soulier J, Díaz-de-Heredia C, Schwartz JD, Sevilla J, Bueren JA; FANCOLEN-1 gene therapy investigators. Río P, et al. Lancet. 2025 Dec 21;404(10471):2584-2592. doi: 10.1016/S0140-6736(24)01880-4. Epub 2024 Dec 3. Lancet. 2025. PMID: 39642902 Clinical Trial.
Education and Training in Peritoneal Surface Oncology.
González-Moreno S, Deraco M, Kusamura S, Bijelic L, Lambert LA, Dromain C, Bibeau F, Liauw W, Reis A, Galan A, Sugarbaker PH. González-Moreno S, et al. Among authors: galan a. J Surg Oncol. 2024 Sep 24. doi: 10.1002/jso.27833. Online ahead of print. J Surg Oncol. 2024. PMID: 39318155 Review.
First-in-Class Mitogen-Activated Protein Kinase p38α: MAPK-Activated Protein Kinase-2 (MK2) Dual Signal Modulator with Anti-inflammatory and Endothelial-stabilizing Properties.
Tulapurkar ME, Shirey KA, Lugkey KN, Luo W, Lal R, Galan A, Mahmoud O, McClean N, Thangaraju K, Cericola D, Lewis D, Murphy WA, Fletcher S, MacKerell AD Jr, Vogel SN, Shapiro P, Hasday JD. Tulapurkar ME, et al. Among authors: galan a. J Pharmacol Exp Ther. 2024 Sep 16:JPET-AR-2024-002281. doi: 10.1124/jpet.124.002281. Online ahead of print. J Pharmacol Exp Ther. 2024. PMID: 39284624 Free article.
Nicotinamide: Bright Potential in Glaucoma Management.
Babighian S, Gattazzo I, Zanella MS, Galan A, D'Esposito F, Musa M, Gagliano C, Lapenna L, Zeppieri M. Babighian S, et al. Among authors: galan a. Biomedicines. 2024 Jul 25;12(8):1655. doi: 10.3390/biomedicines12081655. Biomedicines. 2024. PMID: 39200120 Free PMC article. Review.
Prognostic and therapeutic insights into MIF, DDT, and CD74 in melanoma.
Valdez CN, Sánchez-Zuno GA, Osmani L, Ibrahim W, Galan A, Bacchiocchi A, Halaban R, Kulkarni RP, Kang I, Bucala R, Tran T. Valdez CN, et al. Among authors: galan a. Oncotarget. 2024 Jul 19;15:507-520. doi: 10.18632/oncotarget.28615. Oncotarget. 2024. PMID: 39028303 Free PMC article.
NCCN Guidelines® Insights: Melanoma: Cutaneous, Version 2.2024.
Swetter SM, Johnson D, Albertini MR, Barker CA, Bateni S, Baumgartner J, Bhatia S, Bichakjian C, Boland G, Chandra S, Chmielowski B, DiMaio D, Dronca R, Fields RC, Fleming MD, Galan A, Guild S, Hyngstrom J, Karakousis G, Kendra K, Kiuru M, Lange JR, Lanning R, Logan T, Olson D, Olszanski AJ, Ott PA, Ross MI, Rothermel L, Salama AK, Sharma R, Skitzki J, Smith E, Tsai K, Wuthrick E, Xing Y, McMillian N, Espinosa S. Swetter SM, et al. Among authors: galan a. J Natl Compr Canc Netw. 2024 Jul;22(5):290-298. doi: 10.6004/jnccn.2024.0036. J Natl Compr Canc Netw. 2024. PMID: 39019054
482 results